|
OneSource Speciality Pharma receives SFDA approval for its generic Ozempic®> |
|
OneSource Specialty Pharma Ltd leads losers in 'A' group> |
|
OneSource Specialty Pharma reports consolidated net loss of Rs 88.70 crore in the December 2025 quarter> |
|
OneSource Specialty Pharma to declare Quarterly Results> |
|
OneSource Specialty Pharma allots 23,000 equity shares under ESOP> |
|
OneSource Specialty Pharma reports consolidated net profit of Rs 10.49 crore in the September 2025 quarter> |
|
OneSource Specialty Pharma schedules board meeting> |
|
OneSource Specialty Pharma Ltd - Onesource Specialty Pharma Limited - Amalgamation OR Merger-XBRL> |
|
OneSource Specialty Pharma Ltd - Onesource Specialty Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates> |
|
OneSource Specialty Pharma to hold AGM> |